The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Plasma lipoproteins: genetic influences and clinical implications
Abstract
Susceptibility to the growing global public health problem of cardiovascular disease is associated with levels of plasma lipids and lipoproteins. Several experimental strategies have helped us to clarify the genetic architecture of these complex traits, including classical studies of monogenic dyslipidaemias, resequencing, phenomic analysis and, more recently, genome-wide association studies and analysis of metabolic networks. The genetic basis of plasma lipoprotein levels can now be modelled as a mosaic of contributions from multiple DNA sequence variants, both rare and common, with varying effect sizes. In addition to filling gaps in our understanding of plasma lipoprotein metabolism, the recent genetic advances will improve our ability to classify, diagnose and treat dyslipidaemias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“elevated plasma LDL-C and TG levels are major risk factors (Defesche et al., 2017; Do et al., 2013; Hegele, 2009; Hokanson and Austin, 1996; Rader, 2016)”
From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Hegele, 2009
In the citing paper
“In humans and mice, genetic APOB variants associated with increased levels of apoB are also associated with unusually high plasma concentrations of cholesterol and LDL, which in turn contribute to hypercholesterolemia and heart disease in humans (Benn, 2009; Hegele, 2009).”
From Population genomics reveal recent speciation and rapid evolutionary adaptation in polar bears (2014) · cites this paper as Hegele, 2009
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Global variation in copy number in the human genome
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,377
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–472 of 472
Reis, L. L. T., & Reis, T. (2015)
How Do We Approach Low High-density Lipoprotein Cholesterol in 2011?
Godfrey, E., & Halcox, J. (2011) · European Cardiology Review · doi:10.15420/ecr.2011.7.4.257
Wilson, D. P., de la Torre, A., Brautbar, A., & Hamilton, L. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1189824
Blackett, P. R., & Sanghera, D. K. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/5155
Interleukin 16 in Atherosclerosis and Cardiovascular Disease
Grönberg, C. (2016) · Lund University Publications (Lund University)
Halvorsen, I. (2014) · NORA - Norwegian Open Research Archives
Prevention of Murine Atherosclerosis with Bempedoic Acid
Samsoondar, J. P. (2016) · Scholarship@Western (Western University)
Murillo, A. G. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
Homozygous Familial Hypobetalipoproteinemia: Case Report
Sayın, S. (2016) · Turkiye Klinikleri Journal of Internal Medicine · doi:10.5336/intermed.2015-49037
Matrix metalloproteinase 8: genetic, diagnostic, and therapeutic approaches
Salminen, A. (2016) · Työväentutkimus Vuosikirja
Effect of low density lipoproteins on the progression of chronic lymphocytic leukemia
McCaw, L. (2016) · TSpace (University of Toronto)
La voie ASP-C5L2 : un pont entre l'homéostasie métabolique et l'inflammation
Fisette, A. (2013) · Corpus Université Laval (Université Laval)
Hegele, R. A. (2013)
Self-citationZaburzenia lipidowe u pacjentów z rakiem jamy ustnej i leukoplakią – przegląd piśmiennictwa
Kołciuk, A., Zawadzki, P., & Strużycka, I. (2018) · Dental Forum · doi:10.20883/df.2016.23
Patel, J. P. (2011) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3zk9t
A NOVEL ROLE FOR HDL AND D-HDL IN PULMONARY IMMUNITY
Yaeger, M. J. (2018) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Thiriet, M. (2018) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-3-319-89315-0_7
4. Management of Disorders of Lipoprotein Metabolism-Update-
Ishibashi, S. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.453
Genetic disorders of lipoprotein metabolism
Bhatnagar, D., Schofield, J. D., & Soran, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00014-9 · Cited by 1
Genetic analysis and epistatic interaction association of lipid traits in a C57xBalb/c F2 mice
Kumar, M., Srivastav, A. K., & Parmar, D. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100729
Vomiting in a 40-day-old Infant with Consanguineous Parents
Krueger, C., McWhannell, R., & Schulze, A. (2020) · Pediatrics in Review · doi:10.1542/pir.2018-0287
Transcriptional regulation of endothelial lipase and the role of VEGF-A in lipid metabolism
Kivelä, A. M. (2014) · UEF eRepo (University of Eastern Finland)
Onyilo, P. O., Innih, S. O., Ihemeson, G., Ogereka, L. U., Nweke, S. M., Obele, E. I., & Nwalie, I. N. (2021) · Journal of applied science and environmental management · doi:10.4314/jasem.v25i3.4
The role of systemic metabolism in breast cancer progression
da Fonseca, C. S. R. D. S. G. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Genetics of Cardiovascular Risk in Obesity
Blackett, P. R., & Sanghera, D. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_13
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch6
Lucchi, T. A. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch31
Ordovás, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-375083-9.00171-9
Lipoprotein and Lipid Metabolism
Hegele, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05568-9
Self-citation周, 莉., 汪, 洋., 桂, 建., 李, 文., & 李, 志. (2014) · Scientia Sinica Vitae · doi:10.1360/zc2014-44-1-29
Pharmacogenomic analysis in patients with familial hypercholesterolemia
Dagli-Hernandez, C. (2022) · doi:10.11606/t.9.2022.tde-20052022-121840
Serum Lipids and Lipokines as Prognostic/Diagnostic Biomarkers in Common Cancers
Dogkas, N., Trapali, M., Fountzoula, C., Karikas, G. A., & Καρκαλούσος, Π. (2022) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2022.122011
Ordovás, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.10191-x
CARDIOLOGIA EM FOCO: PREVENÇÃO, DIAGNÓSTICO E TRATAMENTOS ATUAIS
Almeida, A. B., & Horevicht, C. M. (2023) · EPITAYA eBooks · doi:10.47879/ed.ep.2023809
Taipe, B. K. P., & Huarcaya, K. L. R. (2022) · Universidad Privada San Juan Bautista · doi:10.59590/upsjb/ep.msalud.pub/tesis/4017
Decoding the complexities of lipid homeostasis through a unified mouse genetic resource
Filho, C., & Seldin, M. M. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100511
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621409
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621394
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621391
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621385
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621415
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621400
Zou, Y., Zheng, W.-B., Elsheikha, H. M., He, J.-J., Lu, Y., Wang, S., Guo, A., & Zhu, X. (2023) · Figshare · doi:10.6084/m9.figshare.22621403
Multidisipliner Yaklaşımlarla Dislipidemiler
Çalta, A. F., Kar, F., Şahin, M. C., Hacıoğlu, C., Sarı, E., Polat, C., Aydın, Ş., Kılıç, F. S., GÖRGÜ, N., KARAKAYALI, E. M., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.930
Ribeiro, M. G. C., de Almeida, M. E. F., Barakat, B., Parussolo, G. S., de Santana, B. F., & Vinha, L. I. D. L. (2024) · Research Society and Development · doi:10.33448/rsd-v13i7.46239
Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue
Moldovan, I., Fechete, R., Bîrla, A., Orban, E., & Şipoş, R. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-19318-7
Bojic, L. A. (2013) · Scholarship@Western (Western University)
Sheridan, D. A. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Zou, Y., Zheng, W.-B., Sheikha, H. M. E., He, J.-J., Lu, Y.-X., Wang, S., Guo, A., & 朱兴全 (2023) · Nottingham ePrints (University of Nottingham) · doi:10.6084/m9.figshare.22621412
Ying, S., Heung, T., Thiruvahindrapuram, B., Engchuan, W., Yin, Y., Blagojevic, C., Zhang, Z., Hegele, R. A., Yuen, R. K. C., & Bassett, A. S. (2023) · Figshare · doi:10.6084/m9.figshare.24531914
Self-citationZou, Y., Zheng, W.-B., Sheikha, H. M. E., He, J.-J., Lu, Y.-X., Wang, S., Guo, A., & 朱兴全 (2023) · Nottingham ePrints (University of Nottingham) · doi:10.6084/m9.figshare.22621406
Zou, Y., Zheng, W.-B., Sheikha, H. M. E., He, J.-J., Lu, Y.-X., Wang, S., Guo, A., & 朱兴全 (2023) · Nottingham ePrints (University of Nottingham) · doi:10.6084/m9.figshare.22621397
Ying, S., Heung, T., Thiruvahindrapuram, B., Engchuan, W., Yin, Y., Blagojevic, C., Zhang, Z., Hegele, R. A., Yuen, R. K. C., & Bassett, A. S. (2024) · Figshare · doi:10.6084/m9.figshare.24532323
Self-citationHu, X., Fan, J., Ma, Q., Han, L., Cao, Z., Xu, C., Luan, J., Jing, G., Nan, Y., Wu, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19801441
Zou, Y., Zheng, W.-B., Sheikha, H. M. E., He, J.-J., Lu, Y.-X., Wang, S., Guo, A., & 朱兴全 (2023) · Nottingham ePrints (University of Nottingham) · doi:10.6084/m9.figshare.22621388
Lipid metabolism and retinal diseases
Gabrielle, P. (2022) · theses.fr (ABES) · doi:10.70675/f4f26b37z43acz4da3zb19dz906bc95fe494
Ølnes, Å. S., Teigen, M., Strøm, T. B., Arnesen, E., Rimbert, A., Eggen, A. E., & Bjune, K. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344627
Clinical identification of familial chylomicronemia syndrome and novel therapeutic options
Hang, S., & Hegele, R. A. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2661212
Self-citationDogkas, N., Trapali, M., Fountzoula, C., Karikas, G. A., & Καρκαλούσος, Π. (2026) · Review of Clinical Pharmacology and Pharmacokinetics - International Edition · doi:10.61873/rcpp.40.e190445
Vadeevellu, T., Hassan, N., Mohamed, H. J. J., & Bakar, N. S. (2026) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms-04-2026-240
Wang, C. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.112089
Yin, Z., Guo, Y., You, Y., Guan, X., Zhong, G., Jia, C., Wang, W., Jiang, Q., Wen, Y., Li, W., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec1001
Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD
Roberts, R., & Roberts, M. (2026) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1851
Cholesterol: Facts and Opinions by a Non-lipid Cardiologist
Roberts, R. (2026) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1826
Metadata
- Authors
- Hegele, R. A.
- Affiliations
- Western University (CA)
- Corresponding author
- Hegele, Robert A.
- ORCID
- Hegele, Robert A.
- Venue
- Nature Reviews Genetics
- Published
- 2009-02
- Volume
- 10
- Issue
- 2
- Pages
- 109-121
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2068700927
- Cited by
- 462
- References
- 107
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 19 · 2023: 21 · 2022: 32 · 2021: 22 · 2020: 24 · 2019: 19 · 2018: 27 · 2017: 19 · 2016: 31 · 2015: 33 · 2014: 36 · 2013: 26 · 2012: 31
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- serum lipoproteins, plasma lipids, genetic architecture, cardiovascular risk, dyslipidemia, genome-wide association study, rare variants, lipid metabolism, metabolic networks, phenomics, resequencing, disease diagnosis and treatment
- MeSH terms
- Animals, Cholesterol, Humans, Hyperlipoproteinemias, Lipoproteins, Models, Biological, Triglycerides, Genomics, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review